Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Exerc Sci ; 28(2): 264-274, 2016 05.
Article in English | MEDLINE | ID: mdl-26618409

ABSTRACT

Obesity increases the risk of asthma throughout life but the underlying mechanisms linking these all too common threats to child health are poorly understood. Acute bouts of exercise, aerobic fitness, and levels of physical activity clearly play a role in the pathogenesis and/or management of both childhood obesity and asthma. Moreover, both obesity and physical inactivity are associated with asthma symptomatology and response to therapy (a particularly challenging feature of obesity-related asthma). In this article, we review current understandings of the link between physical activity, aerobic fitness and the asthma-obesity link in children and adolescents (e.g., the impact of chronic low-grade inflammation, lung mechanics, and direct effects of metabolic health on the lung). Gaps in our knowledge regarding the physiological mechanisms linking asthma, obesity and exercise are often compounded by imprecise estimations of adiposity and challenges of assessing aerobic fitness in children. Addressing these gaps could lead to practical interventions and clinical approaches that could mitigate the profound health care crisis of the increasing comorbidity of asthma, physical inactivity, and obesity in children.

2.
J Neuroimmunol ; 155(1-2): 161-71, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15342208

ABSTRACT

Multiple Sclerosis (MS) is a chronic inflammatory disease of the CNS which is characterized by large mononuclear cell infiltration and significant demyelination. CXCL8 is a chemo-attractant for both neutrophils and monocytes and triggers their firm adhesion to endothelium. In this study, we demonstrate that serum CXCL8 and CXCL8 secretion from PBMCs are significantly higher in untreated MS patients compared to controls and are significantly reduced in MS patients receiving interferon-beta1a therapy. We suggest that CXCL8 may serve as a marker of monocyte activity in MS and may play a role in monocyte recruitment to the CNS.


Subject(s)
Chemokines, CXC/blood , Chemokines, CXC/immunology , Chemotaxis, Leukocyte/immunology , Intercellular Signaling Peptides and Proteins/blood , Intercellular Signaling Peptides and Proteins/immunology , Monocytes/immunology , Multiple Sclerosis/blood , Multiple Sclerosis/immunology , Adult , Aged , Biomarkers/blood , Central Nervous System/immunology , Central Nervous System/physiopathology , Chemokines, CXC/metabolism , Chemotaxis, Leukocyte/drug effects , Female , Humans , Intercellular Signaling Peptides and Proteins/metabolism , Interferon beta-1a , Interferon-beta/pharmacology , Interferon-beta/therapeutic use , Male , Middle Aged , Monocytes/drug effects , Multiple Sclerosis/drug therapy , Neutrophils/drug effects , Neutrophils/immunology , Predictive Value of Tests , Up-Regulation/drug effects , Up-Regulation/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...